Target intelligence / Profile preview

SLC1A2 antisense RNA 2 (SLC1A2-AS2)

Target
SLC1A2-AS2
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

SLC1A2 antisense RNA 2 (SLC1A2-AS2), also known as AC090625.2, is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the SLC1A2 gene region on chromosome 11. Antisense RNAs are non-protein-coding transcripts that may regulate expression of adjacent or overlapping protein-coding genes through transcriptional interference, RNA-RNA base pairing, or epigenetic mechanisms[6]. SLC1A2-AS2 is part of the growing group of lncRNAs annotated in the human genome, but there are no published functional data, molecular pathway assignments, or disease associations specifically describing the role of SLC1A2-AS2 as of September 2025. It is not currently classified as a therapeutic target, nor are there known drugs, mechanisms, or biomarkers involving this RNA. No substantial errors or misspellings are present in the supplied target name; the entry refers to a probable, though little-studied, human non-coding RNA gene.

Other names
AC090625.2SLC1A2-AS2
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on SLC1A2 antisense RNA 2 (SLC1A2-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC1A2 antisense RNA 2 (SLC1A2-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call